In Focus, October 2008

Article

News In Focus, October 2008

Please click on any of the headlines below to see the full story.

Eye camera could be used as a retina implant
A camera the size and shape of a human eye could have a diverse range of applications, including being used as a retinal implant and in brain monitoring and cardiac stimulation, according to research published in Nature

Can vaccines save sight?
Vaccines may have a role to play against corneal and external ocular disease, because of their success in preventing systemic diseases, according to a presentation given during Cornea Day at the annual meeting of the American Society of Cataract and Refractive Surgery earlier this year. 

Gel decelerates myopia progression
Daily treatment with pirenzepine gel can slow the rate of progressive myopia in children, according to a study published in the August issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus

Dry AMD gene found
The discovery of the first gene known to be associated with dry age-related macular degeneration (AMD) has significant implications for the prevention and treatment of the condition, according to a study published in the October 2, 2008 issue of the New England Journal of Medicine

Flying Eye Hospital heads to China
ORBIS International's Flying Eye Hospital has completed an intensive two-week training programme for approximately 40 ophthalmology residents in Harbin, China. 

European ophthalmologists debate
European Ophthalmology, the social networking group for European ophthalmologists created and moderated by Ophthalmology Times Europe, has recently launched its new discussion forum. 

 

For up-to-date news and announcements, please check the latest news section of our website. Alternatively, please sign up for our weekly newsletter.

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.